Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H23N3OS.2ClH |
Molecular Weight | 366.35 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.CCN(CC)CCOC1=CC=C2N=C(SC2=C1)N(C)C
InChI
InChIKey=FZNXAQMQVKBXDR-UHFFFAOYSA-N
InChI=1S/C15H23N3OS.2ClH/c1-5-18(6-2)9-10-19-12-7-8-13-14(11-12)20-15(16-13)17(3)4;;/h7-8,11H,5-6,9-10H2,1-4H3;2*1H
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
5 % 3 times / day steady, topical Dose: 5 %, 3 times / day Route: topical Route: steady Dose: 5 %, 3 times / day Sources: |
unhealthy, 4 weeks n = 1 Health Status: unhealthy Condition: ringworm Age Group: 4 weeks Sex: F Population Size: 1 Sources: |
Disc. AE: Convulsions... AEs leading to discontinuation/dose reduction: Convulsions (1 patient) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Convulsions | 1 patient Disc. AE |
5 % 3 times / day steady, topical Dose: 5 %, 3 times / day Route: topical Route: steady Dose: 5 %, 3 times / day Sources: |
unhealthy, 4 weeks n = 1 Health Status: unhealthy Condition: ringworm Age Group: 4 weeks Sex: F Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Treatment of superficial dermatomycoses with asterol dihydrochloride. | 1952 Mar 22 |
|
Asterol dihydrochloride in the treatment of dermatophytosis caused by Trichophyton rubrum (purpureum). | 1952 Nov |
|
Experimental studies on drug resistance of dermatophytes. I. The development of drug resistance of Trichophyton mentagrophytes and Microsporum lanosum to undecylenic acid and 2-dimethyl amino-6-(beta-di-ethylaminoethoxy) benzothiazole dihydrochloride (asterol). | 1955 Aug |
|
The effects of sugar deprivation on the anti-fungal properties of asterol; an in vitro study. | 1959 Jul |
|
Extrapyramidal reaction in a patient on combined drug therapy: report of a case. | 1971 Jul-Aug |
|
Seven cases of somnambulism induced by drugs. | 1979 Jul |
|
Synthesis and anticonvulsant activity of some new 2-substituted 3-aryl-4(3H)-quinazolinones. | 1990 Jan |
|
A survey of reported synthesis of methaqualone and some positional and structural isomers. | 2001 Nov 1 |
|
Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. | 2002 Nov |
|
Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. | 2006 Nov 23 |
|
A case of acute myeloid leukemia-M2 with trisomy 4 in addition to t(8;21). | 2008 Jan |
|
Rosiglitazone: can meta-analysis accurately estimate excess cardiovascular risk given the available data? Re-analysis of randomized trials using various methodologic approaches. | 2009 Jan 10 |
|
A new recurring chromosome 13 abnormality in two older patients with de novo acute myeloid leukemia: An Indian experience. | 2009 Sep |
|
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study. | 2010 Aug |
|
The Summary Index of Malaria Surveillance (SIMS): a stable index of malaria within India. | 2010 Feb 11 |
|
Semiautomatic quantification of angiogenesis. | 2010 Jul |
|
Retrospective cohort study of a new infant formula during the first 6 months of life: reflections on growth curves, human milk and formula feeding. | 2010 Nov |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/13673207
Tnichophyton purpureum was treated by various concentrations of Diamthazole (Asterol) in both sugar-free and sugar-containing media. The drug concentration varied from 0.39-6.24 ug/ml. 50% of growth inhibition was achieved at 1 ug/ml in sugar-containing media and at 0.25 ug/ml in sugar-free media.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT002640
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
m681
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | Merck Index | ||
|
3LF09TBB5W
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
136-96-9
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
300000036008
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
8707
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
205-270-5
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
C004723
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY | |||
|
DTXSID40159627
Created by
admin on Fri Dec 15 15:02:53 GMT 2023 , Edited by admin on Fri Dec 15 15:02:53 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD